Antiphospholipid Syndrome

Antiphospholipid Syndrome is an autoimmune disorder in which certain antibodies increase the tendency for blood clots and, in some people, pregnancy complications. With specialist diagnosis, risk assessment and long-term management, many people live active lives and reduce the chance of future clotting events.

Overview

Antiphospholipid Syndrome is an autoimmune clotting disorder in which the immune system makes antibodies that can interfere with normal blood clotting control. These antibodies are called antiphospholipid antibodies. In some people, they increase the risk of clots forming inside veins or arteries, and in pregnancy they may affect the placenta and increase the risk of certain complications.

APS may occur on its own, which is often called primary APS, or alongside another autoimmune condition, most commonly systemic lupus erythematosus. Not everyone with antiphospholipid antibodies has the syndrome. Some people have positive blood tests without ever developing a clot or pregnancy problem, so diagnosis depends on the full clinical picture, not a single test result.

The condition is usually managed by specialists such as rheumatologists, hematologists, neurologists, cardiologists or maternal-fetal medicine doctors, depending on how it affects the person. The main goals are to confirm the diagnosis accurately, reduce the chance of future clots, support safe pregnancy planning when relevant and address related health risks such as smoking, high blood pressure or high cholesterol.

Symptoms

Antiphospholipid Syndrome symptoms depend on where a clot forms and whether pregnancy is involved. A clot in a leg vein may cause one-sided calf or thigh swelling, warmth, tenderness and pain. A clot that travels to the lungs may cause sudden shortness of breath, chest discomfort, rapid heartbeat, coughing or feeling faint, and this needs urgent medical assessment.

Clots can also occur in arteries, including those that supply the brain. This may lead to stroke-like symptoms such as sudden weakness or numbness on one side of the body, difficulty speaking, facial drooping, vision changes, severe dizziness or loss of balance. Some people experience transient symptoms that improve quickly, but they still require prompt evaluation because they can signal a serious clotting risk.

Other features may include recurrent pregnancy loss, pregnancy complications related to placental blood flow, low platelet counts, a lace-like purple skin pattern called livedo reticularis, headaches or heart valve abnormalities. These symptoms are not specific to APS and can occur for many reasons, so a doctor will consider other possible causes before making a diagnosis.

• Possible vein clot symptoms: limb swelling, pain, warmth or redness.
• Possible lung clot symptoms: sudden breathlessness, chest pain, coughing or faintness.
• Possible brain clot symptoms: weakness, speech difficulty, facial droop or vision changes.
• Possible pregnancy-related signs: recurrent miscarriage or complications needing specialist obstetric care.

Causes & Risk Factors

APS is caused by an abnormal immune response that produces antiphospholipid antibodies. These antibodies can interact with proteins involved in clotting and with cells lining blood vessels, which may make clot formation more likely. Why this immune response develops is not fully understood, and it is likely to involve a combination of genetic tendency, immune system factors and environmental triggers.

The best-known antibodies linked with APS are lupus anticoagulant, anticardiolipin antibodies and anti-beta-2 glycoprotein I antibodies. A higher-risk pattern may be present when more than one of these tests is persistently positive, or when antibody levels are consistently high. However, risk is individual, and test results must be interpreted by a clinician together with the person’s history.

Risk of a clot can rise when APS is combined with other clotting or cardiovascular risk factors. These may include smoking, prolonged immobility, major surgery, severe infection, dehydration, pregnancy, the postpartum period, some hormone-containing treatments, high blood pressure, diabetes, kidney disease, high cholesterol or obesity. People with systemic lupus erythematosus or another autoimmune disease may be more likely to be tested for antiphospholipid antibodies, especially if they have had clotting or pregnancy complications.

Diagnosis

Diagnosis of Antiphospholipid Syndrome is based on both clinical criteria and blood tests. A doctor looks for a history of a documented blood clot in a vein or artery, or specific pregnancy complications, together with persistent antiphospholipid antibodies. The antibody tests are usually repeated at least 12 weeks after the first positive result because temporary positivity can occur during infections or other short-term immune changes.

The main laboratory tests include lupus anticoagulant testing, anticardiolipin antibody testing and anti-beta-2 glycoprotein I antibody testing. These tests require careful interpretation because some medicines, acute illness and laboratory methods can affect results. A negative or positive result should not be interpreted in isolation, especially if the person is currently taking blood-thinning medication.

Additional tests may be needed to confirm the location and effect of a clot. These can include ultrasound for suspected leg vein clots, imaging of the lungs for suspected pulmonary embolism, brain imaging for stroke-like symptoms, heart evaluation when valve disease is suspected and obstetric ultrasound monitoring during pregnancy. Doctors may also test for other conditions that can cause similar symptoms, such as inherited clotting disorders, inflammatory diseases, heart rhythm problems or vascular disease.

Treatment Options

Treatment for Antiphospholipid Syndrome is individualized and should be decided by a specialist after assessment of the person’s clotting history, antibody profile, bleeding risk, age, other illnesses, pregnancy plans and current medicines. The main treatment category is blood-thinning therapy, which may include anticoagulant medicines and, in selected situations, antiplatelet treatment. The aim is to reduce the risk of new clots while keeping bleeding risk as low as possible.

People who have had a confirmed clot often need longer-term prevention, but the type and duration of treatment depend on the event and the individual risk profile. Some situations, such as surgery, hospitalization, long travel, pregnancy or the postpartum period, may require temporary adjustments or preventive measures. Patients should not stop or change blood-thinning treatment without medical advice because this can increase the risk of clotting or bleeding complications.

Pregnancy care requires early planning with specialists experienced in high-risk pregnancy and APS. Management may involve pregnancy-safe blood-thinning strategies, closer monitoring of fetal growth and placental function, and coordination between rheumatology, hematology and obstetrics. Many people with APS can have successful pregnancies when risks are recognized and managed early, although care must be tailored to the individual.

Supportive treatment also matters. Doctors may recommend controlling blood pressure, cholesterol and blood sugar, stopping smoking, staying active as appropriate, maintaining hydration, and managing lupus or another autoimmune condition if present. In rare severe forms of APS with widespread clotting, hospital-based urgent treatment may include intensive blood-thinning, immune-modulating therapies and organ support, guided by a specialist team.

Living With / Prognosis

Many people with Antiphospholipid Syndrome live well with regular follow-up and a clear prevention plan. Prognosis depends on factors such as the type of clotting event, antibody pattern, other autoimmune disease, cardiovascular risk factors, pregnancy history and how consistently treatment is followed. Because APS can behave differently from person to person, long-term care works best when it is individualized and reviewed over time.

Living with APS often includes learning the warning signs of clots and understanding how to reduce preventable risks. People taking blood-thinning medicines should ask their doctor about safe activity, dental or surgical procedures, interactions with other medicines or supplements, and what to do if they miss a dose or have bleeding. Wearing medical identification or carrying a medication list can be helpful, especially during travel or emergencies.

Healthy habits do not replace medical treatment, but they support overall vascular health. Regular movement, weight management when appropriate, avoiding smoking, drinking enough fluids, and discussing hormone-based therapies with a doctor are practical steps. For those planning pregnancy, preconception counseling is important so medication choices and monitoring can be arranged before conception whenever possible.

When to See a Doctor

A person should see a doctor if they have had an unexplained blood clot, stroke-like episode, recurrent pregnancy loss or pregnancy complications that may relate to placental blood flow. They should also seek medical advice if they have systemic lupus erythematosus and are concerned about clotting risk, especially before pregnancy, surgery or starting hormone-containing treatment.

Urgent medical care is needed for symptoms that could indicate a serious clot. These include sudden shortness of breath, chest pain, coughing blood, fainting, one-sided leg swelling or pain, sudden weakness or numbness, speech difficulty, facial drooping, severe sudden headache, sudden vision changes or confusion. Even if symptoms improve, prompt assessment is important.

Follow-up should be regular for people already diagnosed with APS, particularly if they take blood-thinning medicines, become pregnant, plan surgery, develop new symptoms or start new medications. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat APS for international patients, coordinating care across rheumatology, hematology, obstetrics, neurology and other specialties when needed.

Frequently asked questions

What is Antiphospholipid Syndrome?

Antiphospholipid Syndrome is an autoimmune disorder that increases the tendency for abnormal blood clots. It is associated with persistent antiphospholipid antibodies and may affect veins, arteries or pregnancy. Diagnosis requires both relevant clinical findings and repeat positive antibody tests.

Is Antiphospholipid Syndrome the same as lupus?

No. APS and lupus are separate conditions, although they can occur together. Some people have primary APS without lupus, while others with systemic lupus erythematosus also develop antiphospholipid antibodies or APS-related complications.

What are the most common Antiphospholipid Syndrome symptoms?

Symptoms usually relate to blood clots or pregnancy complications. A leg clot may cause swelling and pain, a lung clot may cause sudden breathlessness or chest pain, and a brain clot may cause stroke-like symptoms. Some people also have low platelets, skin changes or recurrent pregnancy loss.

How is Antiphospholipid Syndrome diagnosed?

Doctors diagnose APS by combining the medical history with laboratory testing. Blood tests look for lupus anticoagulant, anticardiolipin antibodies and anti-beta-2 glycoprotein I antibodies. Because antibodies can be temporarily positive, testing is usually repeated at least 12 weeks later.

Can Antiphospholipid Syndrome be treated?

Yes, APS can be managed, although treatment depends on the person’s risks and history. Care may involve anticoagulant or antiplatelet medicines, pregnancy-specific treatment, and control of cardiovascular risk factors. The safest plan should be chosen by a specialist after a full assessment.

Can a person with APS have a healthy pregnancy?

Many people with APS can have successful pregnancies with early planning and specialist monitoring. Care is usually coordinated by obstetric and medical specialists familiar with high-risk pregnancy. Anyone with APS who is planning pregnancy should speak with their doctor before conception when possible.

When is APS an emergency?

APS may be an emergency if symptoms suggest a blood clot in the lungs, brain or a major vein. Sudden shortness of breath, chest pain, fainting, one-sided weakness, speech problems, facial drooping or a swollen painful leg should be assessed urgently. Quick evaluation helps doctors confirm the cause and start appropriate care.

References

• European Alliance of Associations for Rheumatology
• American College of Rheumatology
• International Society on Thrombosis and Haemostasis
• British Society for Haematology
• National Organization for Rare Disorders

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.